MX9304197A - Nuevo uso de dimero de lisozina y composiciones que lo contienen. - Google Patents

Nuevo uso de dimero de lisozina y composiciones que lo contienen.

Info

Publication number
MX9304197A
MX9304197A MX9304197A MX9304197A MX9304197A MX 9304197 A MX9304197 A MX 9304197A MX 9304197 A MX9304197 A MX 9304197A MX 9304197 A MX9304197 A MX 9304197A MX 9304197 A MX9304197 A MX 9304197A
Authority
MX
Mexico
Prior art keywords
lysozyme
dimer
dimerized
necrosis factor
tumor necrosis
Prior art date
Application number
MX9304197A
Other languages
English (en)
Spanish (es)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of MX9304197A publication Critical patent/MX9304197A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9304197A 1992-07-13 1993-07-13 Nuevo uso de dimero de lisozina y composiciones que lo contienen. MX9304197A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL92295273A PL173978B1 (pl) 1992-07-13 1992-07-13 Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej

Publications (1)

Publication Number Publication Date
MX9304197A true MX9304197A (es) 1994-02-28

Family

ID=20058087

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304197A MX9304197A (es) 1992-07-13 1993-07-13 Nuevo uso de dimero de lisozina y composiciones que lo contienen.

Country Status (31)

Country Link
US (1) US6132715A (enExample)
EP (1) EP0651654B1 (enExample)
JP (1) JPH07508744A (enExample)
KR (1) KR100289841B1 (enExample)
CN (1) CN1057937C (enExample)
AT (1) ATE252392T1 (enExample)
AU (1) AU677786B2 (enExample)
BG (1) BG63331B1 (enExample)
BR (1) BR9306722A (enExample)
CA (1) CA2140140A1 (enExample)
CZ (1) CZ286725B6 (enExample)
DE (2) DE69333258T2 (enExample)
DK (1) DK0651654T3 (enExample)
ES (1) ES2074037T3 (enExample)
FI (1) FI950144A0 (enExample)
GE (1) GEP20012466B (enExample)
GR (1) GR950300039T1 (enExample)
HU (1) HU218151B (enExample)
MX (1) MX9304197A (enExample)
NZ (2) NZ254135A (enExample)
OA (1) OA10125A (enExample)
PL (1) PL173978B1 (enExample)
PT (1) PT651654E (enExample)
RO (1) RO112580B1 (enExample)
RU (1) RU2145875C1 (enExample)
SG (1) SG52727A1 (enExample)
SK (1) SK282377B6 (enExample)
TW (1) TW259710B (enExample)
UA (1) UA49789C2 (enExample)
WO (1) WO1994001127A1 (enExample)
ZA (1) ZA935046B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
AU5884096A (en) * 1995-05-30 1996-12-18 Lectin Biopharma, Inc. Method of using lectins for agglutination and collection of menstrual flow
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
ITMI981148A1 (it) 1998-05-22 1999-11-22 Therapicon Srl Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
EP1174147A1 (en) * 2000-06-27 2002-01-23 Nika Health Products Limited Reversal of antibiotic resistance with lysozyme dimer
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
RU2320367C1 (ru) * 2006-08-22 2008-03-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУ ДПО РМАПО Росздрава) Способ сопроводительного лечения острого лимфобластного лейкоза
RU2351351C1 (ru) * 2007-08-08 2009-04-10 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) Средство, повышающее неспецифическую сопротивляемость организма к бактериальным эндотоксинам
RU2472467C2 (ru) * 2011-04-13 2013-01-20 Государственное научное учреждение Краснодарский научно-исследовательский ветеринарный институт (ГНУ КНИВИ) Способ профилактики и лечения гастроэнтеритов, обусловленных бактериозами, у телят
CN105106626A (zh) * 2015-09-30 2015-12-02 成都倍加特生物科技有限公司 一种治疗月经期感染的汤剂药物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4020M (enExample) * 1965-01-29 1966-03-21
FR2215201A1 (en) * 1973-01-24 1974-08-23 Theranol Lab Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5533409A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Carcinostatic agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
WO1989011294A1 (en) * 1988-05-26 1989-11-30 Nika Health Care, Inc. Antiviral or antibacterial compound and method of use
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
JP2568447B2 (ja) * 1988-05-31 1997-01-08 ナップ・システムズ・（ユーエスエイ）・インコーポレーテッド 印刷原板を処理するための装置及び方法
WO1991000092A1 (en) * 1989-06-13 1991-01-10 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
US5314816A (en) * 1990-01-08 1994-05-24 Nika Health Products Ltd. Method of preparing lysozyme dimers
MC2243A1 (fr) * 1990-01-08 1993-02-23 Nika Health Products Ltd Procede de preparation de dimeres de la ribonuclease
CA2088352A1 (en) * 1990-08-03 1992-02-04 Klaus M. Esser Tnf inhibitors

Also Published As

Publication number Publication date
DK0651654T3 (da) 2004-02-23
FI950144A7 (fi) 1995-01-12
ES2074037T3 (es) 2004-07-01
SK4095A3 (en) 1995-09-13
KR100289841B1 (ko) 2001-05-15
DE69333258T2 (de) 2004-08-26
ES2074037T1 (es) 1995-09-01
US6132715A (en) 2000-10-17
PL295273A1 (en) 1994-01-24
RU2145875C1 (ru) 2000-02-27
OA10125A (en) 1996-12-18
HUT70973A (en) 1995-11-28
SK282377B6 (sk) 2002-01-07
PT651654E (pt) 2004-03-31
TW259710B (enExample) 1995-10-11
KR950702432A (ko) 1995-07-29
JPH07508744A (ja) 1995-09-28
NZ299377A (en) 2001-02-23
CA2140140A1 (en) 1994-01-20
DE651654T1 (de) 1996-01-04
ATE252392T1 (de) 2003-11-15
FI950144L (fi) 1995-01-12
PL173978B1 (pl) 1998-05-29
CN1087278A (zh) 1994-06-01
DE69333258D1 (de) 2003-11-27
CZ8595A3 (en) 1995-09-13
HU9500098D0 (en) 1995-03-28
WO1994001127A1 (en) 1994-01-20
RO112580B1 (ro) 1997-11-28
BR9306722A (pt) 1998-12-08
UA49789C2 (uk) 2002-10-15
GEP20012466B (en) 2001-06-25
AU677786B2 (en) 1997-05-08
SG52727A1 (en) 1998-09-28
ZA935046B (en) 1994-02-07
HU218151B (hu) 2000-06-28
GR950300039T1 (en) 1995-07-31
BG63331B1 (bg) 2001-10-31
EP0651654B1 (en) 2003-10-22
EP0651654A1 (en) 1995-05-10
NZ254135A (en) 1996-11-26
BG99287A (bg) 1995-08-28
CN1057937C (zh) 2000-11-01
CZ286725B6 (en) 2000-06-14
FI950144A0 (fi) 1995-01-12
AU4568693A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
AR054064A1 (es) Composicio con ingrediente farmaceutico activo en base a canabinoide para formas de dosis mejoradas
AR032556A1 (es) Medicamento de accion inmediata para el tratamiento de la disfuncion sexual
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
BRPI0412211A (pt) composições de liberação controlada
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
ES2176190T3 (es) Inhibidores de la actividad de esteroides sexuales.
ES2194392T3 (es) Derivados alfa-aminoamidicos utiles como agentes analgesicos.
MX9304197A (es) Nuevo uso de dimero de lisozina y composiciones que lo contienen.
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
ES2171933T3 (es) Derivados de androsteno.
DE50112452D1 (de) Transdermales therapeutisches system zur behandlung des restless-legs-syndroms
SE9901573D0 (sv) New compounds
JPH03169812A (ja) トリアセチンを含む活性持続性注射用処方剤
AR030957A1 (es) Composiciones de analgesico y glucosamina
AR033390A1 (es) Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
AR045263A1 (es) Metodo, kit y composicion farmaceutica para tratar infecciones virales
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
AR026631A1 (es) ''3-4-dihidroquinazolinas 5,6-disustituidas''
RU95105517A (ru) Применение димера лизоцима в качестве лекарственного средства и содержащие его композиции
AR036009A1 (es) Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica
TR200103144T2 (tr) Yeni bileşikler
CA2322745C (en) Method of treating neuroma pain
ES2182504T3 (es) Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees